Sign in to follow
Search Results

0 results for 'Teva Pharmaceutical Industries'

You can use to get even better search results
August 16, 2024 | Corporate Counsel

Veteran Legal Chief Who Quit 2 Years Ago—Declaring 'I Need a Break'—Returns to In-House Game

Brett Pletcher has taken the legal reins of the late-stage biopharma Cytokinetic.
3 minute read
June 11, 2024 | New Jersey Law Journal

'We Just Focused on the Factual Record': Kirkland & Ellis Successfully Defends Pharmaceutical Companies in Lipitor MDL

Counsel for Sun Pharmaceutical and Ranbaxy, Devora W. Allon, a partner with Kirkland & Ellis in New York, said that the plaintiffs hired a regulatory expert to say that the Food and Drug Administration moves as fast as it can and that if there had been an earlier target date, the FDA would have met that date.
6 minute read
May 30, 2024 | New Jersey Law Journal

Lawsuits Are Flying Over Generic-Drug Disputes: Surge in Patent Litigation

Five of the suits were filed by Esperion Therapeutics, which seeks to stop competitors from selling generic versions of the company's cholesterol drug Nexletol.
4 minute read
May 22, 2024 | Connecticut Law Tribune

Antitrust Class Actions Emerging Against Big Pharma for Alleged Misuse of Patents

"Teva stifled would-be generic competitors to QVAR because the drug laws do not allow for generic substitution of a given drug-device combination unless the generic is approved for that specific drug-device combination," the complaint alleged.
3 minute read
Himawan v. Cephalon, Inc.
Publication Date: 2024-05-13
Practice Area: Mergers and Acquisitions
Industry: Pharmaceuticals
Court: Court of Chancery
Judge: Vice Chancellor Glasscock
Attorneys:
For plaintiff: Richard L. Renck, Mackenzie M. Wrobel, Duane Morris LLP, Wilmington, DE; John Soroko, Wayne A. Mack, Michael J. Rinaldi, Jessica Priselac, Duane Morris, Philadelphia, PA for plaintiffs.
For defendant: J. Matthew Belger, Kevin R. Shannon, Potter Anderson & Corroon LLP, Wilmington, DE; Jay P. Lefkowitz, P.C., Devora Allon, P.C., John P. Del Monaco, Alexandra I. Russell, Kirkland & Ellis LLP, New York, NY for defendants.
Case number: 2018-0075-SG

Court granted judgment for defendants on plaintiffs' breach of merger agreement claim where record indicated defendants undertook commercially reasonable efforts to develop pharmaceutical treatment and reasonably abandoned development when testing indicated that commercialization would not result in a reasonable profit.

Law Journal Press | Digital Book Section 337 Investigations: Unfair Trade Practice Litigation Before the ITC Authors: Michael G. McManus, Rodney R. Sweetland, III View this Book

View more book results for the query "Teva Pharmaceutical Industries"

May 03, 2024 | New York Law Journal

In $270M National Settlement, Generic Opioid Maker Will Supply Overdose Reversal Pill, Cash

The settlement in principle accounts for New Jersey-based Amneal's role in fueling the national epidemic of opioid addictions and overdoses, New York and California said in separate statements.
3 minute read
March 22, 2024 | Corporate Counsel

Kirkland & Ellis to Represent Apple in Landmark Antitrust Lawsuit

The Kirkland team includes star litigators as well as a partner who spent 13 years at the Federal Trade Commission.
3 minute read
Hayden AI Techs. Inc. v. Safe Fleet Holdings LLC
Publication Date: 2024-03-18
Practice Area: Patent Litigation
Industry: Transportation
Court: U.S. District Court for the Eastern District of New York, U.S. - EDNY
Judge: District Judge Eric Komitee
Attorneys:
For plaintiff:
For defendant:
Case number: 23-CV-3471

Preliminary Injunction Denied; Patent Infringement Claim Not Likely to Succeed

February 05, 2024 | Texas Lawyer

Texas to Receive $21.6M From Publicis Health National $350M Settlement

In the agreed judgement, Publicis Health does not admit any wrongdoing that was alleged by the attorney general.
3 minute read
January 12, 2024 | New York Law Journal

Pharmaceutical Legal and Regulatory Trends To Watch in 2024

This article highlights several notable legal and regulatory developments in 2023 and discusses developments that will continue to shape the pharmaceutical industry in 2024.
8 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • Why Are So Many Law Firms Suddenly Embracing Digital Transformation?

    Brought to you by AllRize

    Download Now

  • 2025 State Legislative Sessions

    Brought to you by LexisNexis®

    Download Now

  • Retention & Online Reputation for Law Firms: 2025 Guide

    Brought to you by Amazing Workplace, Inc.

    Download Now

  • Europe's Escalating Regulatory Framework: Mapping Efforts to Mitigate Supply Chain Risks

    Brought to you by LRN

    Download Now